Vera Therapeutics, Inc.
VERA
$39.96
-$1.21-2.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.51% | 40.78% | 44.86% | 46.12% | 298.75% |
| Total Receivables | -12.93% | 68.10% | 114.39% | 119.87% | 636.91% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 62.65% | 22.35% | 9.16% | 3.42% | -39.12% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 83.30% | 1.77% | 278.55% | 215.14% | -38.18% |
| Total Current Assets | 11.93% | 40.42% | 44.74% | 45.56% | 278.56% |
|
|
|||||
| Total Current Assets | 11.93% | 40.42% | 44.74% | 45.56% | 278.56% |
| Net Property, Plant & Equipment | -23.89% | -25.60% | 73.80% | 58.26% | 42.45% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,848.85% | 2,043.57% | 672.17% | -75.90% | -72.82% |
| Total Assets | 12.06% | 40.41% | 45.62% | 45.50% | 273.51% |
|
|
|||||
| Total Accounts Payable | 185.69% | 290.05% | 182.10% | 77.81% | -31.06% |
| Total Accrued Expenses | 104.84% | 19.05% | 67.92% | 62.08% | 65.39% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -62.98% | -74.73% | -59.59% | -47.65% | -39.12% |
| Total Finance Division Other Current Liabilities | -22.02% | -- | -- | -- | -- |
| Total Other Current Liabilities | -22.02% | -- | -- | -- | -- |
| Total Current Liabilities | 110.69% | 58.25% | 82.18% | 50.55% | 13.76% |
|
|
|||||
| Total Current Liabilities | 110.69% | 58.25% | 82.18% | 50.55% | 13.76% |
| Long-Term Debt | 47.65% | 47.91% | 48.15% | 1.68% | 1.62% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -22.24% | -18.42% | 390.77% | 157.45% | 76.92% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 65.82% | 49.21% | 58.81% | 14.21% | 6.32% |
|
|
|||||
| Common Stock & APIC | 31.46% | 51.28% | 51.14% | 51.52% | 152.84% |
| Retained Earnings | -64.96% | -60.30% | -58.81% | -51.99% | -49.22% |
| Treasury Stock & Other | 100.00% | -15.61% | 217.11% | 478.03% | 56.57% |
| Total Common Equity | 4.74% | 37.99% | 42.82% | 51.33% | 467.59% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.74% | 37.99% | 42.82% | 51.33% | 467.59% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.74% | 37.99% | 42.82% | 51.33% | 467.59% |
|
|
|||||